Literature DB >> 16682136

Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.

Chris R Kelsey1, Kim L Light, Lawrence B Marks.   

Abstract

PURPOSE: To analyze local-regional patterns of failure after surgical resection of non-small-cell lung cancer (NSCLC). METHODS AND MATERIALS: This retrospective analysis included 61 patients who underwent resection of NSCLC at Duke University Medical Center. Inclusion into the study required the following: margin-negative resection, no neoadjuvant/adjuvant radiation therapy (RT), first recurrence involving a local-regional site, and imaging studies available for review. Sites of intrathoracic disease recurrence were documented. Diagrams were constructed that illustrated sites of failure on the basis of lobe of primary tumor. Failure rates were compared by application of a two-tailed Fisher's exact test.
RESULTS: All patients had CT imaging for review, and 54% also had PET imaging. The median number of local-regional recurrent sites was two (range, 1-6). For all patients, the most common site of failure was the bronchial stump/staple line (44%), which was present more often in those who had a wedge resection than in those who had a more radical procedure (79% vs. 34%, p=0.005). Patients with initial nodal involvement (pN1-2) were not more likely to have involvement of the mediastinum than were patients with pN0 disease (64% vs. 72%, p=0.72), but were more likely to have involvement of the supraclavicular fossa (27% vs. 4%, p=0.04). Mediastinal involvement, without overt evidence of hilar involvement, occurred in 59% of patients. Left-sided tumors tended to involve the contralateral mediastinum more frequently than did right-sided tumors. Patterns of failure after resection are diagrammed and follow a fairly predictable pattern on the basis of involved lobe.
CONCLUSIONS: These data may help clinicians construct postoperative RT volumes that are smaller than ones traditionally utilized, which may improve the therapeutic ratio.

Entities:  

Mesh:

Year:  2006        PMID: 16682136     DOI: 10.1016/j.ijrobp.2006.02.007

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer.

Authors:  Masatoshi Nakamura; Kayoko Ohnishi; Hitoshi Ishikawa; Kensuke Nakazawa; Toshihiro Shiozawa; Toshiyuki Okumura; Ikuo Sekine; Yukio Sato; Nobuyuki Hizawa; Hideyuki Sakurai
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

Review 2.  Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.

Authors:  Cécile Le Péchoux
Journal:  Oncologist       Date:  2011-03-04

Review 3.  Post-operative radiation therapy.

Authors:  Amaury Paumier; Cécile Le Péchoux
Journal:  Transl Lung Cancer Res       Date:  2013-10

Review 4.  Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.

Authors:  Yelena Krupitskaya; Billy W Loo
Journal:  Curr Treat Options Oncol       Date:  2009-04-22

Review 5.  Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer.

Authors:  Josephine Feliciano; Steven Feigenberg; Minesh Mehta
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

6.  Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.

Authors:  Luigi Moretti; David S Yu; Heidi Chen; David P Carbone; David H Johnson; Vicki L Keedy; Joe B Putnam; Alan B Sandler; Yu Shyr; Bo Lu
Journal:  Oncologist       Date:  2009-11-06

7.  Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Nicholas G Zaorsky; Xian-Zhi Zhao; Zhi-Qiang Wu; Bo Jiang; Yong-Chun Song; Hong-Qing Zhuang; Feng-Tong Li; Lu-Jun Zhao; Chang-Li Wang; Kai Li; Ping Wang; Zhi-Yong Yuan
Journal:  Oncotarget       Date:  2015-06-20

8.  Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer.

Authors:  Xuquan Jing; Xue Meng; Xindong Sun; Jinming Yu
Journal:  Onco Targets Ther       Date:  2016-02-19       Impact factor: 4.147

9.  18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.

Authors:  Ping Huang; Xiang Zhao; Weiyuan Xiao; Yuqi Dong; Guangyu Hu
Journal:  Oncotarget       Date:  2017-06-13

Review 10.  Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.

Authors:  Cecile Le Péchoux; Olaf Mercier; Deborah Belemsagha; Ryan Bouaita; Benjamin Besse; Elie Fadel
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.